Document is current

Article History

Received: 10 March 2026

Accepted: 15 May 2026

First Online: 26 May 2026

Declarations

:

: Anthony Brown, Carla Simonetto, and Monica Foyaca are employees of ISDIN. Thierry Passeron has received grants and/or honoraria from AbbVie, ACM Pharma, Almirall, Amgen, Astellas, Beiersdorf, Bristol Myers Squibb, Calypso, Caudalie, Celgene, Galderma, Genzyme/Sanofi, GlaxoSmithKline, Incyte Corporation, ISDIN, ISIS Pharma, Janssen, LEO Pharma, L’OREAL, Eli Lilly, NAOS, Novartis, Pfizer, Roivant, Sun Pharmaceuticals, SVR, Symrise, Takeda, UCB, and VYNE Therapeutics. He is the cofounder of NIKAIA Pharmaceuticals. Yolanda Gilaberte has acted as a consultant for Almirall, ISDIN, Cantabria Labs, Abbvie, Incyte, and Pfizer. Jaime Piquero-Casals is a consultant for ISDIN. Sergio Schalka has received grants and/or honoraria from Aché, Beiersdorf, Cantabria, FQM Brasil, ISDIN, L’OREAL, and NAOS. Henry W. Lim has served as investigator for Incyte, La Roche Posay, Pfizer, and PCORI; consultant for ISDIN, Beiersdorf, Ferndale, L’Oréal, Eli Lilly, Zerigo Health, Skinosive, Kenvue, Cantabria Labs, NAOS, and Boehringer Ingerheim, and speaker on general educational session for La Roche-Posay, Cantabria Labs, Pierre Fabre, NAOS, Uriage, Pfizer, ISDIN, Clinuvel, and Rxilient. Jean Krutmann serves as a consultant to / IUF obtains funding from: AbbVie, Activen, Amway, Beiersdorf, bitop, Blue Lagoon, Evonik, ISDIN, Laboratoire Native, La Roche-Posay, L’Oreal, Mary Kay, Meitu, Mistine, Mibelle, SinoCell Biotechnology, Skinceuticals, Stada, Symrise, and Vichy.

: This article is based on previously conducted studies and does not contain any new studies with human participants or animals.